Log in

Relevant bibliographies by topics / Diabetics – Diet therapy

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Diabetics – Diet therapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 10 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diabetics – Diet therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diabetics – Diet therapy"

1

Fernando, Ricardo E. "Diet therapy among young diabetics in the Philippines." Indian Journal of Pediatrics 56, S1 (January 1989): S67—S70. http://dx.doi.org/10.1007/bf02776467.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Evseev, A. "Sweeteners in Diabetes Mellitus Diet." Bulletin of Science and Practice 6, no. 9 (September 15, 2020): 192–97. http://dx.doi.org/10.33619/2414-2948/58/18.

Full text

Abstract:

According to the statistics submitted by the World Health Organization, sugar consumption has been constantly increasing worldwide. Craving for sugary foods is a fairly common form of addiction. Poor nutrition, caused by external and internal factors, provokes an increase in the incidence of obesity, arterial hypertension, and diabetes mellitus. This deadly triad annually takes hundreds of thousands of lives across the globe, since the pathologies listed above often go hand in hand, being interconnected. The article discusses the problem of using artificial and natural sweeteners in diet therapy for diabetes mellitus. Nutritionists around the world are concerned about how to preserve the usual sweet taste of dishes and drinks for patients with diabetes, on the one hand, yet avoiding additional harm to their health, and possibly improving the quality of diabetic life, on the other. The author summarized the materials on recent clinical studies on the subject discussed. The article analyses the four sweeteners most commonly used by diabetics: fructose, sorbitol, xylitol and honey stevia (Stevia rebaudiana Bertoni) leaf powder. Considerable attention is paid to the history of the appearance of each of the substances and medicinal raw materials studied. The author indicates their safe properties and possible disadvantages of use, as well as side effects.

APA, Harvard, Vancouver, ISO, and other styles

3

Bellmann, O. "Therapy of gestational diabetes." Acta Endocrinologica 113, no. 3_Suppl (August 1986): S50—S55. http://dx.doi.org/10.1530/acta.0.111s0050.

Full text

Abstract:

Abstract. Even minor abnormalities of maternal carbohydrate metabolism may influence foetal development. This study aimed at examining the relations between impaired glucose tolerance and blood glucose behavior under a standardized diet in late pregnancy and at looking for the obstetrical and neonatal outcome after normalization of blood glucose profiles in gestational diabetics. The study included 97 women in the second half of pregnancy. Severely abnormal blood glucose profiles were observed in most patients with impaired glucose tolerance who had a fasting capillary blood glucose concentration above 4.7 mmol/l. Normalization could usually only be achieved by combining a strict dietary regimen with insulin treatment. The obstetrical and neonatal outcome in the group of patients treated with diet plus insulin was similar to that in the group of patients treated with diet alone.

APA, Harvard, Vancouver, ISO, and other styles

4

Kavula, Michael P. "Diet and Exercise in the Management of Diabetes." Journal of Pharmacy Practice 5, no. 5 (October 1992): 254–59. http://dx.doi.org/10.1177/089719009200500504.

Full text

Abstract:

Insulin-dependent diabetes mellitus (IDDM) individuals can benefit from using current nutritional concepts to control their intake of carbohydrates, protein, fats, and other nutrients to aid in the control of blood glucose and lipid levels by building consistency of meal times and injections of insulin into their overall program. The NIDDM patient, on the other hand, will need a diet that offers appropriate calories to sustain daily activities, but also promote weight loss. Exercise has important physiological and psychological benefits for all individuals including diabetics. Exercise programs need to be designed for the individual's ability and used as adjunctive therapy to improve glucose control and reduce cardiovascular risk factors.

APA, Harvard, Vancouver, ISO, and other styles

5

Davì, Giovanni, Mario Belvedere, Sergio Vingneri, Isabella Catalano, Carlo Giammarresi, Salvatore Roccaforte, Agostino Consoil, and Andrea Mezzetti. "Influence of Metabolic Control on Thromboxane Biosynthesis and Plasma Plasminogen Activator Inhibitor Type-1 in Non-insulin-dependent Diabetes mellitus." Thrombosis and Haemostasis 76, no. 01 (1996): 034–37. http://dx.doi.org/10.1055/s-0038-1650518.

Full text

Abstract:

SummaryWe have previously shown that tight metabolic control by insulin therapy reduced thromboxane-dependent platelet activation in noninsulin-dependent diabetes mellitus (NIDDM) patients. The present study was undertaken to determine whether a similar effect could be obtained without switching diabetics in secondary failure to insulin treatment. For this purpose, we gave strict diet and exercise advise program and adjusted on a weekly basis the oral antidiabetic therapy (glipizide) that 26 patients with NIDDM had been given over the previous months.Basal measurements of urinary ll-dehydro-TXB2 and PAI-1 confirmed previous findings of enhanced levels of these parameters in NIDDM patients with macrovascular disease in comparison to age-and sex-matched controls. After 2-6 weeks, 16 patients achieved tight metabolic control associated with significant reduction of both thromboxane biosynthesis and PAI-1 levels; 10 patients remained in poor control and no significant decrease of both parameters was observed.We conclude that reduction of in-vivo platelet activation and PAI-1 antigen levels after metabolic improvement obtained by frequent reassessment of sulphonylurea therapy together with strict diet and exercise programs may have beneficial effects on the progression of diabetic micro- and macrovascular disease.

APA, Harvard, Vancouver, ISO, and other styles

6

Akhtar, Sakina, and Mushtaq Ahmad. "Myths About Medical nutrition therapy (MNT) in Kashmiri diabetics." JMS SKIMS 20, no. 2 (December 9, 2017): 69–72. http://dx.doi.org/10.33883/jms.v20i2.29.

Full text

Abstract:

Methods:- 50 patients of diabetes who were attending OPD Endocrinology Department were taken randomly over 3 months in the study. patients were enquired about the diet they were avoiding or taking with the belief of Glycaemic control. Result:- Of the 50 patients of the study 17 were males and 33 females.32 belonged to rural and 18 urban areas. 32 were illiterate and only 18 were literate.43(80%) patients were avoiding sweet fruits like Banana, Mango and Apple. 42 (84%)were found avoiding underground vegetables like Potato, Turnip, Radish, Carrots and Onions. 17 (34%)were taking unlimited rice. 22(44%) were consuming refined oils.22 (44%) had tried bitter gourd for glycaemic control. 12(24%)had tried Fenugreek seeds for Glycaemic control.22 (44%) were avoiding lunch. 45(90%) were avoiding Dhals like Rajma. 11(22%) were having Miscellaneous beliefs. JMS 2017;20(2):69-72

APA, Harvard, Vancouver, ISO, and other styles

7

Arshad, Shoaib, Amreen Khan, Veena Melwani, Soumitra Sethia, Angelin Priya, and Satish Melwani. "A study to assess the efficacy of medical nutritional therapy in reducing blood sugar level in type 2 diabetic patients." International Journal Of Community Medicine And Public Health 5, no. 7 (June 22, 2018): 2901. http://dx.doi.org/10.18203/2394-6040.ijcmph20182619.

Full text

Abstract:

Background: Physicians in India have less time for Diet consultation, despite the fact that diet planning plays an important role in management of diabetes mellitus type II. Medical nutritional therapy is defined as Nutritional diagnostic therapy, and counseling services for the purpose of disease management. The objective of the study was to study the efficacy of medical nutrition therapy in type 2 diabetics.Methods: A study was done on residents of Fatehgarh and Shaheed Nagar area of Bhopal. 44 patients with known history of diabetes with age 45 years or above were selected by house to house visit using purposive sampling. Subjects were divided in 2 groups. 1. Intervention group- known cases of diabetes mellitus type 2 with medical nutritional therapy. 2. Non Intervention group- known cases of diabetes mellitus type 2 without medical nutritional therapy. Diet plan according to the calorie requirement on the basis of the desired body weight was prepared and prescribed to the subjects of group 1. Monthly home visits for blood glucose monitoring was done.Results: The mean RBS of group 1 was 200mg and of group 2 was 194. The mean RBS of group 1 decreased by 6.5% in second reading and 8.2% in third reading.Conclusions: Only 19 out of 22 Diabetics belonging to intervention group adhered to the prescribed medical nutrition therapy. The reason being poor patient compliance because of casual attitude towards health. Better results could be obtained if the study duration was longer and HbA1c was considered.

APA, Harvard, Vancouver, ISO, and other styles

8

Wiasa, I. Wayan. "Yoga Theraphy Untuk Penyakit Diabetes Melitus." JURNAL YOGA DAN KESEHATAN 1, no. 1 (July 7, 2020): 65. http://dx.doi.org/10.25078/jyk.v1i1.1545.

Full text

Abstract:

Diabetes Mellitus disease or abbreviated as DM is one of the chronic diseases caused by carbohydrate, protein and fat metabolism abnormalities and the development of macrovascular and neurological complications. The disease is characterized by elevated blood glucose levels (hyperglycemia) and allows for a decrease in the ability to respond to insulin or decrease insulin formation by the pancreas. DM can attack anyone from adolescence to adulthood. This disease becomes one of the categories of diseases that are dangerous, because it becomes one of the causes of disability, chronic complications that can spread to the heart, blood vessels, kidneys, eyes and nerves, even this disease can lead to death. If not prevented as early as possible, people with Diabetes Mellitus will continue to increase throughout the year, especially with a fast-paced and instant life, causing a variety of stress and prolonged stress that also trigger the emergence of this disease. Various alternative healing options for patients such as a healthy diet, exercise, until the consumption of drugs. Among the ways of treatment, exercise or exercise is still in demand by most people, one of which is often incorporated yoga practice with meditation so-called yoga theraphy is a special yoga therapy for diabetics. Some studies reveal that the movements in yoga can overcome the problems experienced by diabetics, of course, through regular exercise and balanced with a healthy diet.<br /><br />

APA, Harvard, Vancouver, ISO, and other styles

9

Gyldenkerne, Christine, Kevin Kris Warnakula Olesen, Morten Madsen, Troels Thim, Lisette Okkels Jensen, Bent Raungaard, Henrik Toft Sørensen, Hans Erik Bøtker, and Michael Maeng. "Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease." Diabetes and Vascular Disease Research 16, no. 4 (April 3, 2019): 351–59. http://dx.doi.org/10.1177/1479164119836227.

Full text

Abstract:

Objective: We examined the risk of myocardial infarction associated with glucose-lowering therapy among diabetes patients with and without obstructive coronary artery disease. Methods: A cohort of patients with type 1 or type 2 diabetes (n = 12,030), who underwent coronary angiography from 2004 to 2012, were stratified by presence of obstructive (any stenosis ⩾50%) coronary artery disease and by type of diabetes treatment: diet, non-insulin treatment and insulin (±oral anti-diabetics). The primary endpoint was myocardial infarction. Adjusted hazard ratios were calculated using diet-treated patients without coronary artery disease as reference. Results: In patients without coronary artery disease, risk of myocardial infarction was similar in patients treated with non-insulin medication (adjusted hazard ratio 0.70, 95% confidence interval 0.27–1.81) and insulin (adjusted hazard ratio 0.76, 95% confidence interval 0.27–2.08) as compared to diet only. In patients with coronary artery disease, the risk of myocardial infarction was higher than in the reference group and an incremental risk was observed being lowest in patients treated with diet (adjusted hazard ratio 3.79, 95% confidence interval 1.61–8.88), followed by non-insulin medication (adjusted hazard ratio 5.42, 95% confidence interval 2.40–12.22), and highest in insulin-treated patients (adjusted hazard ratio 7.91, 95% confidence interval 3.51–17.82). Conclusion: The presence of obstructive coronary artery disease defines the risk of myocardial infarction in diabetes patients. Glucose-lowering therapy, in particular insulin, was associated with risk of myocardial infarction only in the presence of coronary artery disease.

APA, Harvard, Vancouver, ISO, and other styles

10

Setyaji, Diyan Yunanto, and Fransisca Shinta Maharini. "Ganyong-kelor snack bar's glycemic index as a diet for diabetics." Jurnal Gizi Indonesia (The Indonesian Journal of Nutrition) 9, no. 2 (June 30, 2021): 105–10. http://dx.doi.org/10.14710/jgi.9.2.105-110.

Full text

Abstract:

Background: Lack of insulin or the inability of cells to respond to insulin causes high blood glucose levels or hyperglycemia, a hallmark of diabetes. Consumption of foods with a low glycemic index and high fiber has been shown to provide the same benefits as pharmacological therapy in the control of postprandial hyperglycemia and can prevent the incidence of hypoglycemia in people with diabetes. Ganyong (Canna edulis) is a food source of carbohydrates and fiber. Kelor (Moringa oliefera) contains protein and some phytochemical compounds which have a hypoglycemic effect.Objectives: The objective of the study was to analyze the glycemic index of ganyong-kelor snack bars as a diet for diabetics.Materials and Methods: Ten respondents fasted for 10 hours and checked their fasting blood glucose levels, then consumed 105 grams of bread as the reference food. Every 30 minutes after eating, the blood glucose levels were checked. In the following week, after fasted, all respondents consumed 157 grams of a ganyong-kelor snack bar and checked their blood glucose levels every 30 minutes.Results: Every 100 grams of ganyong-kelor snack bar contains 230.13 kcal, 31.97 grams of carbohydrates, 9.25 grams of fat, and 4.75 grams of protein. In this study, bread was used as a reference food. If bread was corrected with glucose as a reference food, the glycemic index of the ganyong-kelor snack bar was 38.08. The calculation of the glycemic load used the converted-glycemic index and the total carbohydrates contained in 100 grams of the food. Ganyong-kelor snack bar had a glycemic load value of 12.10.Conclusions: Ganyong-kelor snack bar had good nutritional content and was categorized as food with a low glycemic index. The hypoglycemic effect of the ganyong-kelor snack bar came from its high fiber content. Ganyong-kelor snack bar can be consumed as a healthy snack for diabetic people.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Diabetics – Diet therapy"

1

Chan, Yim-ting Tina, and 陳艷婷. "Effect of a diabetes specific formula in the blood sugar and blood lipid profiles and nutritional status of type II diabetes living innursing homes : a prospective randomized trial." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31971507.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Netjes, Robert Bryan. "Relationships between weight, HOMA IR, leptin, adiponectin and interleukin-6, before and after a calorie restricted diet intervention, and in a 6-8 month post diet period, in overweight and obese individuals at risk for type 2 diabetes." Pullman, Wash. : Washington State University, 2008. http://www.dissertations.wsu.edu/Thesis/Fall2008/R_Netjes_120308.pdf.

Full text

Abstract:

Thesis (M.Nurs.)--Washington State University, December 2008.
Title from PDF title page (viewed on Mar. 4, 2009). "Intercollegiate College of Nursing." Includes bibliographical references (p. 71-87).

APA, Harvard, Vancouver, ISO, and other styles

3

Rudrich, Horst R. "The reduction of the diabetic syndrome in the C57Bl/KsJ (db/db) diabetic mouse by diet-restriction and exercise." CSUSB ScholarWorks, 1985. https://scholarworks.lib.csusb.edu/etd-project/425.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bourdon, Janette Lynne. "Consumer health applications effect on diet and exercise behaviours inpeople with diabetes mellitus, type 2." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48422101.

Full text

Abstract:

Background: Despite growing utilization of mobile phones and websites for consumers seeking health care advice, the area is largely understudied. A niche market for these applications is in diabetes care. Since diabetes is a chronic condition requiring daily monitoring it is a good candidate for consumer health informatics and especially interactive websites and mobile phone applications. As the obesity epidemic continues, so too the prevalence of type 2 diabetes continues to rise. This chronic condition can lead to major complications and high medical cost. It is on the rise in countries all over the world, and beginning to impact people at younger ages. Low cost interventions are being explored to mitigate these complications and cost. Objective: To examine the effectiveness of consumer health informatics, such as websites, personal digital assistants, and mobile phone applications that claim to help people with diabetes self-monitor diet and exercise behaviours to lose weight. Methods: A search for relevant literature was conducted using PUBMED, Cochrane, and IEEE Xplore, with the search terms: (mhealth OR mobile health OR phone OR web* OR ehealth OR internet OR ICT) AND diabetes AND (diet* OR exercise OR physical activity). Also, a bibliographic search was done to identify any studies that were missed in the initial search. The search was not limited to any date range, but articles were identified from the time period of September 2000 through April 2012. Only articles in English were included. Studies were included if the program included an interactive logging feature for diet and/or physical activity. Studies that looked at type 1 disbetes were excluded. Results: A total of 10 original studies were found that met the inclusion criteria. Including 2 qualitative design, 1 randomized trial, and 7 randomized control trials. There was a great deal of heterogeneity among the studies. Delivery methods varies, studies including the following are: *  Mobile device only: 3 *  Website only: 6 *  Website plus mobile device: 1 Many different outcome measures were used across the studies including: behavioural, physiological, psychosocial, as well as usability and satisfaction. Overall, adherence and follow up were low. Dietary tracking generally appears not to be as effective as broad goals such as, “each more fruits and vegetables”. Exercise tracking was more effective at increasing physical activity. Message boards and peer support did not show an increase in effectiveness, but personal online coaches and personalized emails showed promising results. Usability and satisfaction was high in those that reported it, but the large number of dropouts are not considered in this. Conclusions: At this time, consumer health informatics does not seem to be an effective solution in facilitating significant behavior change for people who have type 2 diabetes. Future programs should look at ways to increase adherence and usage of the programs because the people who did use the programs daily benefited more than sporadic users. Components that showed promising results are access to a personal online coach, personalized weekly emails, integration with a pedometer that automatically uploads to a tracking program, and broader food related goals. Further testing is necessary to determine if this type of intervention is effective.
published_or_final_version
Public Health
Master
Master of Public Health

APA, Harvard, Vancouver, ISO, and other styles

5

Sheikh, Mona Hanif, of Western Sydney Hawkesbury University, Faculty of Science and Technology, and School of Food Sciences. "Diet and self-care in Pakistani diabetic patients." THESIS_FST_SFS_Sheikh_M.xml, 1993. http://handle.uws.edu.au:8081/1959.7/91.

Full text

Abstract:

Two hundred non-insulin dependent diabetic patients, predominantly from three health facilities in Lahore, Pakistan were assessed for metabolic control, weight status, diabetes knowledge, and six areas of diabetes self-care activities as well as dietary intake. A questionnaire was administered in an interview format followed by a 24-hour recall of dietary intake. Glycosylated haemoglobin status were determined on ninety subjects. The care levels appear to be inadequate for satisfactory diabetes control. Only 5 subjects had HbA1c levels within the normal range, while 21 showed extremely high levels. Complications and associated medical conditions were present in more than half of the sample. Diabetes knowledge averaged 4 correct responses out of a total of 11. Considerable variation was noted in the reported care regimens including the dietary regimen. Analysis revealed a number of areas of concern including high fat intake and a low intake of leafy vegetables, pulses and fruit which along with nutrient analysis results suggests a low fibre intake. The data points towards the need for improved diabetes education at all levels and identifies several areas of concern to be address
Master of Science (Hons)

APA, Harvard, Vancouver, ISO, and other styles

6

Magrane, Elijah James. "The Effects of Blueberry Consumption on Satiety and Glycemic Control." Fogler Library, University of Maine, 2009. http://www.library.umaine.edu/theses/pdf/MagraneEJ2009.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lee, Dexter L. "Effects of endothelin-1 on coronary smooth muscle after chronic diabetes, atherogenic diet, and therapy." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9974651.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Saugur, Anusooya. "Management of type 2 diabetes mellitus : a pharmacoepidemiological review." Thesis, Nelson Mandela Metropolitan University, 2011. http://hdl.handle.net/10948/1635.

Full text

Abstract:

Type 2 diabetes mellitus (DM) is a progressive disease characterised by hyperglycaemia caused by defects in insulin secretion and insulin action. In early stages of type 2 DM, dietary and lifestyle changes are often sufficient to control blood glucose levels. However, over time, many patients experience β cell dysfunction and require insulin therapy, either alone or in combination with oral agents. There are guidelines available to structure the management of this disease state, including both the use of oral hypoglycaemic agents and or insulin. Besides health complications, there are economic burdens associated with the management of type 2 diabetes mellitus. The aim of this study was to determine the management of type 2 DM in a South African sample group of patients drawn from a large medical aid database. The objectives of the study were: to establish the prevalence of type 2 DM relative to age, examine the nature of chronic comorbid disease states, establish trends in the prescribing of insulin relative to other oral hypoglycaemic agents, investigate cost implications, and determine trends in the use of blood and urine monitoring materials by patients. The study was quantitative and retrospective and descriptive statistics were used in the analysis. DM was found to be most prevalent amongst patients between 50 and 59 years old. Results also demonstrated that 83% of DM patients also suffered from other chronic comorbid diseases, with cardiovascular diseases, especially hypertension and hypercholesterolaemia being the most prominent. This study also revealed that DM is predominantly managed with oral hypoglycaemic agents. Changes in drug prescribing, for chronic disease states such as DM may have medical, social and economic implications both for individual patients and for society and it is envisaged that the results of this study can be used to influence future management of DM. Keywords: Pharmacoepidemiology, management, type 2 diabetes mellitus

APA, Harvard, Vancouver, ISO, and other styles

9

Souza, Siane Campos de. "Avaliação dos efeitos de terapias com células de medula óssea em modelo experimental de diabetes mellitus tipo 2." reponame:Repositório Institucional da FIOCRUZ, 2010. https://www.arca.fiocruz.br/handle/icict/4302.

Full text

Abstract:

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-08-29T20:39:47Z No. of bitstreams: 1 Siane Campos. Avaliação dos efeitos de terapias com celulas de medula óssea modelo experimental de diabetes mellitus tipo 2.pdf: 7027812 bytes, checksum: 4b12aa1315741fb327aacac8f55889a7 (MD5)
Made available in DSpace on 2012-08-29T20:39:47Z (GMT). No. of bitstreams: 1 Siane Campos. Avaliação dos efeitos de terapias com celulas de medula óssea modelo experimental de diabetes mellitus tipo 2.pdf: 7027812 bytes, checksum: 4b12aa1315741fb327aacac8f55889a7 (MD5) Previous issue date: 2010
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil
O diabetes mellitus tipo 2 (DM2) é uma disfunção metabólica que afeta milhões de pessoas em números crescentes em todo o mundo. É caracterizado pela resistência dos tecidosalvo à insulina e/ou defeitos na sua secreção, acarretando uma hiperglicemia crônica, que pode gerar danos no sistema cardiovascular, nervoso, olhos, rins e fígado e representam um ônus para os sistemas de saúde. Doença de etiologia múltipla, o DM2 resulta da interação entre predisposição genética e fatores ambientais, destacando-se a obesidade. O tratamento do DM2 geralmente envolve mudanças de hábito e drogas anti-hiperglicemiantes ou hipoglicemiantes que podem acarretar efeitos colaterais. As recentes descobertas sobre a plasticidade e o potencial terapêutico das células-tronco de medula óssea indicam uma possível aplicação destas no tratamento do DM2 e suas complicações. Para investigar esse potencial, foi estabelecido um modelo de diabetes em camundongos C57Bl/6 através da administração de dieta hipergordurosa. Após o período de indução, os animais apresentavam obesidade, hiperglicemia, intolerância à glicose, proteinúria e esteato-hepatite não-alcoólica. Camundongos C57Bl/6 fêmeas não desenvolvem obesidade, hiperglicemia e DM2 quando submetidas à mesma dieta que os machos. Apenas os machos foram então tratados com células mononucleares de medula óssea e acompanhados durante seis meses. A terapia com células mononucleares de medula óssea não reduz o peso corpóreo dos animais obesos e diabéticos. Três e seis meses após a terapia, não foi observada redução da glicemia de jejum dos animais.Três meses após a terapia, observou-se redução da intolerância a glicose nos animais alimentados com dieta high-fat.Houve uma redução da fibrose perissinusoidal no fígado após 3 meses de terapia e esta diferença se manteve até 6 meses após a terapia.
Type 2 diabetes mellitus (T2DM) is a metabolic disorder that affects millions of people and grows worldwide. It is characterized by insulin resistance in peripheral tissues and/or impaired insulin secretion, leading to chronic hyperglycemia associated with long-term consequences that include damage and dysfunction of the cardiovascular system, eyes, kidneys and nerves. T2DM is a multifactorial disease determined by genetic and environmental factors, especially obesity. The usual treatment involves antihyperglycemic and hypoglycemic drugs that can provoke undesirable side effects. Recent findings on hematopoietic stem cell plasticity and therapeutic potential suggest their use as an alternative treatment for T2DM and its consequences. In order to investigate this potential, a model of diabetes was induced in C57Bl/6 mice through administration of a high-fat diet. Animals developed obesity, hyperglycemia, glucose intolerance, proteinuria and nonalcoholic steato-hepatitis. Female C57Bl/6 mice do not developed obesity, hyperglycemia and T2DM when submitted the male’s diet. After the induction period, only the male mice were treated with bone marrow mononuclear cells and observed during 6 months. Cell mononuclear from bone marrow therapy do not reduced body weight from obesity and diabetes animals. Three and six months after the therapy, we do not observed reduction from glycemia. Three months after the therapy, observed reduction glucose intolerance in mice high-fat fed. Reduction in fibrosis perisinusoidal liver after thee months from therapy and this difference still until six months after therapy.

APA, Harvard, Vancouver, ISO, and other styles

10

Giaco, Karen M. "Medical Nutrition Therapy in a Chronic Care Model for the Treatment of Diabetes—A Baseline Study as Precursor to a Pilot Study Collaborative." Akron, OH : University of Akron, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=akron1176300411.

Full text

Abstract:

Thesis (M.S.)--University of Akron, School of Family and Consumer Science-Nutrition and Dietetics , 2007.
"May, 2007." Title from electronic thesis title page (viewed 4/26/2009) Advisor, Deborah Marino; Faculty readers, Richard Steiner, Evelyn Taylor, Cinda Chima; School Director, Richard Glotzer; Interim Dean of the College, James Lynn; Dean of the Graduate School, George R. Newkome. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Diabetics – Diet therapy"

1

Recipes for diabetics. 2nd ed. New York: Bantam Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Recipes for diabetics. New York, NY: Perigee Books, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Halmon, Mary. The diabetic way: Everyday recipes for diabetics. [Tex.?: MVG Cookbooks, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Little, Billie. Recipes for diabetics. 2nd ed. New York: Bantam Books, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

1952-, Maynard Lucian, Duncan Theodore G, and Pitkin Julia M, eds. Cooking for diabetics. Nashville, Tenn: Rutledge Hill Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jezl, James L. Diabetes control: Cook book and diet guide for diabetics : over 500 recipes that really work for diabetics. St. Charles, Ill: Kane Trail Publishers, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jennifer, McDonald, and Cox Margaret 1944-, eds. Simply delicious recipes for diabetics. [Garden City Park, N.Y.?]: Avery, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Blanchard, Pat. Basic menus & recipes for diabetics. Plaquemine, La: Creole Pub. Co., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Denman, Joan Erskine. All new cookbook for diabetics and their families. Edited by Dustan Harriet P, Denman Joan E, and University of Alabama in Birmingham. Dept. of Dietetics. Birmingham, Ala: Oxmoor House, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Karin, Cadwell, ed. Super sweet treats for diabetics. New York: Sterling Pub., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Diabetics – Diet therapy"

1

Maeda, Yoshitaka, and Tatsuo Shiigai. "Diet Therapy in Diabetic Nephropathy." In Contributions to Nephrology, 50–58. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000100996.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kume, Shinji. "Nutrition and Diet Therapy for DKD." In Diabetic Kidney Disease, 87–100. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-9301-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Metzger, Boyd E. "Diet and Medical Therapy in the Optimal Management of Gestational Diabetes Mellitus." In Nestlé Nutrition Workshop Series: Clinical & Performance Program, 155–69. Basel: KARGER, 2006. http://dx.doi.org/10.1159/000094449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Li, Jie Jack. "Diabetes Drugs." In Laughing Gas, Viagra, and Lipitor. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195300994.003.0011.

Full text

Abstract:

Diabetes mellitus is a multisystem disease associated with the loss of control of physiological glucose concentrations in the blood. The disease is broadly broken down into two types based on factors that include age, acuteness of onset, underlying glucose-handling deficit, and therapy. Type 1 diabetes usually manifests acutely in the young, secondary to some underlying insult (possibly infectious) to the islet cells of the pancreas, resulting in an absolute lack of insulin. Type 2 diabetes is more frequently associated with maturity, obesity, and gradually increasing blood glucose concentrations; it may be asymptomatic for some time and discovered on routine glucose screening. In fact, as weight increases among the general population of the developed world, type 2 diabetes is becoming an epidemic. Type 1 diabetes always requires insulin replacement therapy, whereas type 2 can frequently be controlled with diet, weight loss, and oral medications that enhance residual pancreatic function. Diabetes has been known since antiquity. In fact, the term diabetes mellitus comes from the Greek meaning “siphon and honey” due to the excess excretion (siphon or faucet) of hyperglycemic (sweetened, or honeyed) urine. In ancient times, most cases of diabetes were of type 1, with acute onset in the young, which was often fatal. Type 2 diabetes was extremely rare when sources of nutrition were scarce and obesity was not prevalent. Diabetes was also known as “wasting” because diabetics were not able to metabolize the sugar content of food and eventually died from wasting away. Because of the effect of excess blood glucose, the blood of the diabetic is hyperosmolar (concentrated), and this triggers compensatory thirst (in an attempt to dilute the hyperglycemia and return the blood to a normal concentration). This excess thirst results in the common diabetic symptom of polydipsia (excessive drinking secondary to thirst, resulting in the urge to drink frequently) and polyuria (excess urination). Even before many modern diagnosis tools became available, savvy doctors could diagnose diabetic men just by looking at their shoes for the telltale white spots from urine with high sugar content. In fact, tasting urine samples of diabetics was a routine diagnostic tool for diabetes. Even the breath of a severe diabetic was sweet—a sickly smell as a result of acidosis. In addition, it has been mentioned that ants would track to the urine of diabetics.

APA, Harvard, Vancouver, ISO, and other styles

5

Sharma, Rekha, and Swapna Chaturvedi. "Diet Therapy in Diabetes Mellitus." In Basics of Clinical Nutrition, 353. Jaypee Brothers Medical Publishers (P) Ltd., 2008. http://dx.doi.org/10.5005/jp/books/10085_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

"Diabetes and the kidney." In Oxford Desk Reference Nephrology, edited by Jonathan Barratt, Peter Topham, Sue Carr, Mustafa Arici, and Adrian Liew, 285–97. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198777182.003.0007.

Full text

Abstract:

Diabetic renal disease is the commonest cause of end-stage renal disease (ESRD) in the Western world and is rapidly becoming the leading cause in developing countries. The following chapters provide valuable insights into the epidemiology, pathophysiology, and pathology of diabetic renal disease with a focus on the clinical presentation, diagnosis, natural history, and progression of the disease. Many patients with diabetic renal disease suffer from microvascular and macrovascular complications of diabetes, including diabetic retinopathy, neuropathy, cardiovascular, and peripheral vascular disease. The authors discuss the available treatment approaches including lifestyle, diet, and exercise. In addition, they cover the importance of maintaining healthy blood pressure and glycaemic control to improve outcomes and the pharmacological treatments available. The authors describe the range of hypoglycaemic agents now available as well as insulin treatment. Ultimately, many patients will require management of complications of diabetes. Often they develop progressive renal impairment that requires renal replacement therapy with dialysis and transplantation, which are also discussed.

APA, Harvard, Vancouver, ISO, and other styles

7

Wright, Alexander D. "What is diabetes?" In Diabetic Retinopathy: Screening to Treatment (Oxford Diabetes Library), 1–6. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198834458.003.0001.

Full text

Abstract:

The definition of diabetes, its causes, complications, and basic treatments are outlined. Diabetes mellitus is characterized by increased concentrations of glucose in the blood. The basic defect is a relative or absolute lack of insulin, the pancreatic hormone promoting the transfer of glucose into tissues for storage as glycogen or fat. Type 1 diabetes is due to autoimmune destruction of insulin-producing cells and insulin therapy is essential. Type 2 diabetes is due to a relative lack of insulin, often with tissue insulin resistance. It is a slowly progressive condition so that, although diet and lifestyle changes are often effective initially, oral therapy and insulin may be required eventually. Diabetes is associated with long-term vascular complications affecting both small and large arteries.

APA, Harvard, Vancouver, ISO, and other styles

8

Perez-Martinez, Pablo, Antonio Garcia-Rios, Javier Delgado-Lista, Francisco Perez-Jimenez, and Jose Lopez-Mir. "Nutritional Therapy in Diabetes: Mediterranean Diet." In Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications. InTech, 2011. http://dx.doi.org/10.5772/20916.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sharma, Rekha. "Chapter-22 Diet Therapy in Diabetes Mellitus." In Essentials of Oral Medicine, 353–66. Jaypee Brothers Medical Publishers (P) Ltd., 2008. http://dx.doi.org/10.5005/jp/books/10290_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Karalliedde, Janaka, and Giancarlo Janaka. "Diabetic nephropathy." In Oxford Textbook of Endocrinology and Diabetes, 1935–46. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199235292.003.1521.

Full text

Abstract:

Diabetic nephropathy is classically defined as a rise in urinary albumin excretion rate (UAER), often associated with an increase in blood pressure, with concomitant retinopathy but without evidence of other causes of renal disease (1). It is characterized by a progressive decline in glomerular filtration rate (GFR), eventually resulting in end-stage renal disease. Diabetic nephropathy occurs in approximately 30–35% of type 1 and type 2 patients and tends to cluster in families. These families also show a predisposition to cardiovascular disease and hypertension—and, hypertension, or a predisposition to it, appears a major determinant of diabetic renal disease. These data taken together clearly suggest an individual susceptibility to this complication. The phases of diabetic nephropathy based on urine albumin excretion status and GFR are shown in Table 13.5.3.1 (2). Histological changes of diabetic glomerulopathy are present in over 95% of patients with type 1 diabetes and albuminuria (UAER >300 mg/day) and in approximately 85% of type 2 diabetic patients who develop albuminuria with concomitant diabetic retinopathy (1, 2). In the absence of diabetic retinopathy nearly 30% of patients with type 2 diabetes and proteinuria have nondiabetic renal lesions (1). The all-cause mortality in patients with diabetic nephropathy is nearly 20–40 times higher than that in patients without nephropathy. In recent years it has become apparent that renal disease and cardiovascular disease are closely related and diabetic nephropathy is acknowledged as an independent and powerful risk factor for cardiovascular disease (3). Many patients with diabetes and renal impairment die from a cardiovascular disease event before they progress to end-stage renal disease. Diabetic nephropathy is the most common cause of end-stage renal disease worldwide and represent about 30–40% of all patients receiving renal replacement therapy in the Western World.

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diabetics – Diet therapy"

1

Barzizza, F., G. Belloni, E. Trespi, A. Venturini, and I. Richichi. "HYPOGLYCEMIC EFFECT OF INDOBUFEN,AN ANTIAGGREGATING AGENT,IN ELDERLY DIABETIC PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643100.

Full text

Abstract:

Inibition of platelet aggregation is of value in therapy for Transient Ischemic Attacks(TIA).We observed 2 consecutive elderly patients with type 2 diabetes mellitus(DM)and TIA,in whom chronic treatment with Indobufen(I) provoked a reduction of blood glucose levels; for this reason we started a cross-over study to assess the possible hypoglycemic effect of I in elderly patients with DM.Ten patients(5 males,mean age 75±5 years)with DM and TIA have been included in our study. After 1 month of diet treatment(1)all patients took either placebo tablets 2)or I 200mg every 12 hours for 4 weeks in a random cross-over fashion.After each period a daily blood glucose profile has been obteined. Results are the following:Indobufen in the dose of 200 mg every 12 hours has an hypoglycemic effect. This side effect can be dangerous in patients already treated with hypoglycemic agents, but can be usefull as a single drug therapy for aged patients with type 2 diabetes mellitus and atherosclerotic vascular disease.

APA, Harvard, Vancouver, ISO, and other styles

2

Schleußner, E., F. Weschenfelder, and T. Groten. "Überprüfung des Qualitätsfaktors Ergebnisqualität in der leitliniengerechten Therapie des Gestationsdiabetes – lassen sich die Morbiditätsprävalenzen bei GDM denen ohne GDM angleichen?" In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641921.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kloos, C., S. Groos, N. Müller, UA Müller, and B. Hagen. "Wird die antidiabetische Therapie bei Menschen mit Diabetes mellitus Typ 2 und eingeschränkter Nierenfunktion adäquat angepasst? Befunde aus dem Disease-Management-Programm (DMP) in Nordrhein." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641946.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bawadi, Hiba, and Zumin Shi. "Protein Intake among Patients with Diabetes is Linked to Poor Glycemic Control." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0149.

Full text

Abstract:

Background: Nutrition therapy is considered a key component of diabetes management. Highprotein diets are recently gaining more popularity. Knowledge regarding the potential glycemic effect of protein in people with type 2 diabetes has been a particular interest. Methods: This study is a cross-sectional study based on NHANES data collected on participants aged 40 years and older who attended the surveys cohorts of 2011–2012 and 2013–2014. Data on 1058 participants were included in the analysis. Glycemic control was measured as HbA1c level and patients were categorized into quartiles of daily protein intake. Analysis adjusted for age, gender, race and energy intake muscle strength (quartile), sedentary activity, income to poverty ratio, education, smoking, alcohol drinking and BMI. Logistic regression models were produced to investigate the impact of high protein intakes on odds of poor glycemic control (HbA1c ≥ 7). Results: After controlling for muscle strength (quartile), sedentary activity, income to poverty ratio, education, smoking, alcohol drinking and BMI; patients in Quartile 4 for protein intake had 260% increased risk for poor glycemic control as compared to those in quartile 1. These results are limited because the analysis did not consider the source of protein (animal vs plant). Further studies are needed.

APA, Harvard, Vancouver, ISO, and other styles

5

Heinemann, L., G. Freckmann, D. Ehrmann, G. Faber-Heinemann, S. Guerra, D. Waldenmaier, and N. Hermanns. "Effekte von rtCGM bei Erwachsenen mit Typ-1-Diabetes und Hypoglykämieproblemen, die mit einer multiplen Insulininjektions-Therapie behandelt werden: Ergebnisse der multizentrischen, randomisierten kontrollierten HypoDE-Studie." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641892.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Seufert, J., L. Blonde, Lori Berard, A. Saremi, Y. Huang, V. Aroda, and D. Raccah. "Einfluss der Typ-2-Diabetesdauer auf die Wirkung von iGlarLixi gegenüber Insulin glargin 100 E / ml bei einer basalunterstützten oralen Therapie (BOT): Eine Subanalyse der LixiLan-L-Studie." In Diabetes Kongress 2021 – 55. Jahrestagung der DDG. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1727315.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Fritsche, A., S. Pscherer, M. Pfohl, H. Anderten, K. Pegelow, and J. Seufert. "Umstellung des Basalinsulins auf Insulin glargin 300 E/ml (Gla-300) nach Versagen der Basis-Bolus-Therapie (ICT) mit einem anderen Basalinsulin verbesserte bei Typ-1-Diabetespatienten die Blutzucker-Einstellung – 6-Monats-Ergebnisse der Toujeo-Neo-T1DM-Studie." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641939.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Pscherer, S., M. Pfohl, A. Fritsche, H. Anderten, K. Pegelow, and J. Seufert. "Umstellung des Basalinsulins auf Insulin glargin 300 E/ml (Gla-300) nach Versagen einer Basis-Bolus- (ICT) oder einer basalunterstützten oralen Therapie mit einmal täglich prandialem Insulin (BOTplus) mit einem anderen Basalinsulin verbesserte bei Typ-2-Diabetespatienten die glykämische Kontrolle – 6-Monats-Ergebnisse der Toujeo-Neo-T2DM-Studie." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641911.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diabetics – Diet therapy"

1

Chen, Shu-xian, Mei-ying Ao, Xing-qian Yi, Qing-ying He, Qian Chen, Rui-rong Zhang, Jia-wei Dong, Jia-hui Zhang, and Xiao-fan Chen. Effectiveness of Traditional Chinese medicine syndrome differentiation diet therapy in intervention of type 2 diabetes: protocol for a systematic review and meta-analysis of randomised controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2021. http://dx.doi.org/10.37766/inplasy2021.6.0097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!